AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5
slide-6

Diabend-MEX 30 Tablet ER

Prescription Icon
Prescription Required

Marketer

Bal Pharma Ltd

Salt Composition

Gliclazide (30mg) + Metformin (500mg)

Overview Diabend-MEX 30 Tablet ER

Glucodual 30 ER tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Glucodual 30 ER with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle significantly influences diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Always carry a rapid-acting glucose source (e.g., sugary snacks, juice) to manage hypoglycemia. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Inform your doctor of any history of heart disease before commencing treatment; pregnancy or breastfeeding necessitates medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Diabend-MEX 30 Tablet ER

Non-insulin-dependent diabetes

Major Benefits of Diabend-MEX 30 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Diabend-MEX 30 Tablet ER whole; do not damage the tablet by chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Diabend-MEX 30 Tablet ER:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Diabend-MEX 30 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Diabend-MEX 30 Tablet ER whole; avoid chewing, crushing, or breaking it. Take it with a meal.

How Diabend-MEX 30 Tablet ER works:

Gliclazide and metformin are combined in the extended-release Diabend-MEX 30 tablet to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Diabend-MEX 30 Tablet ER and alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Diabend-MEX 30 Tablet ER is contraindicated during pregnancy due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Diabend-MEX 30 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Diabend-MEX 30 Tablet ER cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is recommended, and regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Diabend-MEX 30 Tablet ER cautiously, potentially requiring dosage modification. Severe liver disease contraindicates its use; mild to moderate cases warrant initiating treatment with a reduced dose. Physician consultation is advised.

What if you forget to take Diabend-MEX 30 Tablet ER :

Should you forget a Diabend-MEX 30 Tablet ER dose, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Diabend-MEX 30 Tablet ER

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Diabend-MEX 30 Tablet ER

Diabend-MEX 30 ER tablets contain gliclazide and metformin, a dual-agent therapy for adult patients with type 2 diabetes mellitus. This medication helps manage blood sugar levels when combined with a healthy diet and regular physical activity. Gliclazide's mechanism involves stimulating insulin secretion from the pancreas, while metformin reduces hepatic glucose production and enhances insulin sensitivity. This formulation is unsuitable for managing type 1 diabetes.
Diabend-MEX 30 ER tablets are linked to several common adverse reactions. These include low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal discomfort, loose stools, headache, and upper respiratory infections. While uncommon, serious side effects such as lactic acidosis are possible. Prolonged treatment may also result in vitamin B12 deficiency.
Indeed, Diabend-MEX 30 Tablet ER can induce hypoglycemia (low blood glucose). Manifestations of low blood sugar encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of unease or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advisable.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential, albeit uncommon, side effect of Diabend-MEX 30 Tablet ER (metformin). This complication, also termed Metformin-Associated Lactic Acidosis (MALA), constitutes a medical emergency. To minimize risk, its use is contraindicated in individuals with pre-existing kidney impairment, the elderly, and heavy alcohol consumers. Warning signs of lactic acidosis can encompass muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, and bradycardia. Should these symptoms manifest, discontinue Diabend-MEX 30 Tablet ER immediately and seek urgent medical attention.
Prolonged Diabend-MEX 30 Tablet ER administration can indeed lead to vitamin B12 deficiency. This is because the medication impairs the stomach's absorption of vitamin B12. Untreated, this deficiency may manifest as anemia, neurological issues, including tingling and numbness in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive measures proposed by some studies involve supplemental vitamin B12 intake at least annually.
Patients exhibiting hypersensitivity to any Diabend-MEX 30 Tablet ER ingredient or additive should not use this medication. Its use is contraindicated in individuals with moderate to severe renal impairment or those experiencing metabolic acidosis, including diabetic ketoacidosis.
Consuming alcohol concurrently with Diabend-MEX 30 Tablet ER is unsafe. This combination risks dangerously low blood sugar (hypoglycemia) and elevates the probability of lactic acidosis.
Diabend-MEX 30 ER tablets contain gliclazide and metformin, a dual-action medication for managing type 2 diabetes mellitus in adults. This treatment enhances blood sugar control when combined with a healthy diet and regular physical activity. Gliclazide functions by stimulating insulin secretion from the pancreas, while metformin reduces hepatic glucose production and enhances insulin responsiveness. This specific formulation is unsuitable for type 1 diabetes.
Diabend-MEX 30 Tablet ER may cause common adverse reactions such as low blood sugar (hypoglycemia), changes in taste perception, nausea, abdominal discomfort, loose stools, headache, and upper respiratory infections. Serious, though uncommon, side effects include lactic acidosis. Prolonged treatment may result in vitamin B12 deficiency.
Indeed, Diabend-MEX 30 Tablet ER can induce hypoglycemia. Manifestations of low blood sugar encompass nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. This adverse effect is amplified by skipped or delayed meals, alcohol consumption, excessive physical exertion, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is recommended.
Diabend-MEX 30 Tablet ER can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an infrequent adverse reaction to metformin. Risk factors include pre-existing kidney impairment, advanced age, and significant alcohol consumption. Symptoms such as muscle aches, weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia warrant immediate discontinuation of Diabend-MEX 30 Tablet ER and prompt medical attention.
Prolonged Diabend-MEX 30 Tablet ER use can indeed lead to vitamin B12 deficiency. This is because the medication impedes the stomach's absorption of vitamin B12. Left unaddressed, this deficiency may result in anemia, neurological issues, including tingling and numbness in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and impaired balance. To mitigate these risks, supplemental vitamin B12 is recommended annually by some experts.
Patients with hypersensitivity to any Diabend-MEX 30 Tablet ER ingredient or inactive component should not use this medication. Its use is also contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol concurrently with Diabend-MEX 30 Tablet ER is unsafe. This combination may exacerbate hypoglycemia and heighten the risk of lactic acidosis.
Diabend-MEX 30 Tablet ER
87
MRP 106
17% off